Clinical Trials on Pompe Disease (Late-onset) in Switzerland

Total 22 results

Emma Marie Caroline Slack
University of Zurich; University Children's Hospital, Zurich

Completed

Characterization of Intestinal Microbiota Stability in Preterm Born Neonates (NEC)

Late-Onset Neonatal Sepsis | Necrotising Enterocolitis

Switzerland
AO Innovation Translation Center

Active, not recruiting

Evaluation of a Modern System to Allow for Growth in Children With Scoliosis Versus a Conventional Treatment

Early Onset Scoliosis

United Kingdom, Switzerland
University Hospital, Geneva

Recruiting

Genetic Risks for Childhood Cancer Complications in Switzerland (GECCOS)

Childhood Cancer | Genetic Predisposition | Late Effect

Switzerland
University Hospital, Basel, Switzerland
Medtronic; Freiwillige Akademische Gesellschaft (FAG) Basel

Recruiting

The Basel CardioInsightTM - 3D Mapping Study (BigMap)

New-onset Atrial Fibrillation (NOAF)

Switzerland
HES-SO Valais-Wallis
Hilfiker Roger

Recruiting

Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial) (HOPE)

Alzheimer Disease, Early Onset

Switzerland
Aktiia SA

Recruiting

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Hypertension | Blood Pressure | Heart Rate

Switzerland
Luzerner Kantonsspital

Completed

Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis

Sepsis

Switzerland
AB2 Bio Ltd.

Completed

Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease

Still's Disease, Adult-Onset

Germany, France, Switzerland
University Hospital, Basel, Switzerland

Completed

Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study (Hypo-BEAR)

Bariatric Surgery | Postprandial Hypoglycemia | Late Dumping Syndrome

Switzerland
University Children's Hospital, Zurich
Sanofi

Completed

Development of an Assessment Tool for Health-related Quality of Life in Children and Adolescents With Pompe Disease (Pompe_HrQol)

Pompe Disease

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (Co-STAR)

Transcatheter Aortic Valve Replacement | Atrial Fibrillation New Onset | Pacemaker | Colchicine

Switzerland
Alain Kaelin
Clinical Trial Unit Ente Ospedaliero Cantonale

Recruiting

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

Idiopathic Parkinson's Disease (at Later Stage)

Switzerland
Fliegerärztliches Institut
University of Lausanne

Completed

Low Intensity Exercise in Different Normobaric/Hypobaric Normoxic/Hypoxic Conditions. (Hypoxia)

Heart Rate Variability | Cerebral Oxygenation | Oxygen Saturation | Baro-reflex Sensitivity | EEG, Microstates | Cerebral Blood Flow Regulation | Concentration Performance

Switzerland
Georg Kägi, MD
University Hospital, Basel, Switzerland; Cantonal Hospital of Aarau, Switzerland

Recruiting

Capsaicin for Post-stroke Dysphagia (CADYS)

Dysphagia, Late Effect of Stroke

Switzerland
Nelly Pitteloud

Recruiting

GnRH Therapy on Cognition in Down Syndrome

Down Syndrome | Cognitive Decline | Alzheimer Disease, Early Onset | Olfaction Disorders

Switzerland
Novartis

Completed

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Partial Onset Seizures

United States, Italy, Germany, Taiwan, Hungary, Switzerland, Bulgaria, Korea, Republic of, Slovakia, Poland
Idorsia Pharmaceuticals Ltd.

Completed

Tezosentan in Acute Heart Failure (VERITAS 1)

Acute Heart Failure | Acute Decompensation of Chronic Heart Failure | New Onset of Heart Failure

United States, United Kingdom, Israel, Switzerland, Austria, Denmark, France, Germany, Greece, Poland
Novartis Pharmaceuticals

Completed

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients (B-Confident)

Cryopyrin-associated Periodic Syndromes (CAPS) | Familial Cold Autoinflam Syn (FCAS) | Muckle-wells Syn (MWS) | Neonatal Onset Multisystem Inflam Disease (NOMID)

Switzerland, United States, Germany, Norway, Austria
UCB Biopharma SRL

Terminated

A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy (DUET)

Drug-Resistant Epilepsy | Focal-Onset Seizures

United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerlan... and more
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Familial Cold Autoinflammatory Syndrome | Muckle-Wells Syndrome | Neonatal Onset Multisystem Inflammatory Disease | Cryopyrin-associated Periodic Syndromes

Germany, France, Belgium, Canada, Spain, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Familial Cold Autoinflammatory Syndrome | Muckle-Wells Syndrome | Neonatal Onset Multisystem Inflammatory Disease | Cryopyrin-associated Periodic Syndromes

Germany, France, Belgium, Canada, Spain, Switzerland, United Kingdom
Genzyme, a Sanofi Company

Completed

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease (COMET)

Glycogen Storage Disease Type II;Pompe's Disease

Czechia, Taiwan, Belgium, Germany, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, Denmark, France, Hungary, Italy, Japan, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Switzerland, Turk... and more

Clinical Trials on Pompe Disease (Late-onset) in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations